ライフサイエンスコーパス: after discharge

1 scharge) and late readmissions (8 to 30 days after discharge).

2 for early discharge (with follow-up shortly after discharge).

3 rge), and 3 months after post-test (6 months after discharge).

4 .73 m2 for at least 3 months during the year after discharge.

5 rogression to end-stage renal disease (ESRD) after discharge.

6 e readmission and mortality within 8-30 days after discharge.

7 discharge, which persisted for up to 5 years after discharge.

8 patient visit with a clinician within 7 days after discharge.

9 ort on patient admission to the hospital and after discharge.

10 was not significantly associated with death after discharge.

11 nt death and death during follow-up over 1 y after discharge.

12 ased risk of mortality diminished at 2 years after discharge.

13 expected they could manage themselves alone after discharge.

14 with 46.3% occurring between days 30 and 90 after discharge.

15 tality from infections while in hospital and after discharge.

16 e AMI hospitalization, 37.7% became adherent after discharge.

17 dmitted with first-time MI and alive 30 days after discharge.

18 after ingestion of egg approximately one day after discharge.

19 <7 d and >/=7 d) and readmission within 30 d after discharge.

20 icant in landmark analyses beginning 30 days after discharge.

21 admission timing was determined from the day after discharge.

22 payments during hospitalization and 30 days after discharge.

23 spiratory or neurosensory morbidity or death after discharge.

24 t the time of the procedure, and 24-72 hours after discharge.

25 ing hospitalization or to prevent recurrence after discharge.

26 lization is associated with statin intensity after discharge.

27 intensive care) wards and again three months after discharge.

28 ce that persisted throughout the entire year after discharge.

29 e hospital and 1405 infants were followed up after discharge.

30 ion, and 41.5% of the UC-VTEs were diagnosed after discharge.

31 on were significantly less likely to go home after discharge.

32 7 and 14 during treatment as well as 8 weeks after discharge.

33 ommendation to use counseling and medication after discharge.

34 offered patients coordinated continuing care after discharge.

35 ences had largely resolved by 9 to 12 months after discharge.

36 ts at 3 months and 382 patients at 12 months after discharge.

37 ns are effective only if treatment continues after discharge.

38 gnosis during hospitalization and at 1 month after discharge.

39 riates to adjust for subsequent CKD and ESRD after discharge.

40 ation, and 11% (n=174) were impaired 1 month after discharge.

41 rction, bleeding, and recurrent renal injury after discharge.

42 lative mortalities at 1, 3, 6, and 12 months after discharge.

43 s, and statins, respectively, within 30 days after discharge.

44 ve medication use is increased in the months after discharge.

45 e, 10% of patients to be seen as outpatients after discharge.

46 d not receive rehabilitation within 3 months after discharge.

47 %; 95% CI, 0.79%-0.82%) experienced a stroke after discharge.

48 f death or rehospitalization within 6 months after discharge.

49 d nursing facilities or with home healthcare after discharge.

50 completed the follow-up survey 2 to 8 weeks after discharge.

51 d with decreased physical function for years after discharge.

52 s were assessed at presentation and 3 months after discharge.

53 gnoses regardless of age, sex, race, or time after discharge.

54 rviving patients were followed up for 1 year after discharge.

55 is readmitted to the hospital within 30 days after discharge.

56 ement strategies to prevent adverse outcomes after discharge.

57 F rehospitalization at 6 months or 12 months after discharge.

58 Readmission timing was determined by day after discharge.

59 r in both cumulative and consecutive periods after discharge.

60 ents receive during a hospital admission and after discharge.

61 discharge from hospital, and 2 and 6 months after discharge.

62 r AHF remain very high either in-hospital or after discharge.

63 ovements on the majority of outcomes 2 years after discharge.

64 h hyperkalemia, predominantly within 30 days after discharge.

65 ion, and 35% of patients were alive 6 months after discharge.

66 aids, and individualized telephone follow-up after discharge.

67 ions during hospitalization and at intervals after discharge.

68 ly 15% of these patients were alive 6 months after discharge.

69 fset by higher medical utilization and costs after discharge.

70 site and categorized as occurring before or after discharge.

71 for improving outcomes and helping patients after discharge.

72 e physician and more nursing facility visits after discharge.

73 ifferences in the quality of care during and after discharge.

74 on, and (4) risk-adjusted 30-day readmission after discharge.

75 ssions (odds ratio, 1.08 [CI, 1.02 to 1.14]) after discharge.

76 al-level rates of early outpatient follow-up after discharge.

77 Of 5827 postoperative deaths, 23.6% occurred after discharge.

78 tion were categorized as occurring before or after discharge.

79 All-cause readmission within 30 days after discharge.

80 rehensive cognitive assessments 3 and 12 mos after discharge.

81 hs afterward, and were followed for 6 months after discharge.

82 neurosensory impairment, and 12 infants died after discharge.

83 eductions in hospital 30-day mortality rates after discharge.

84 6% of patients over an average of 3.5 months after discharge.

85 There were no vascular complications after discharge.

86 ization for GI bleed and received octreotide after discharge.

87 ilitation and outpatient cardiologist visits after discharge.

88 received oral versus intravenous antibiotics after discharge.

89 rates of suicide remain high for many years after discharge.

90 high mortality rate within the first months after discharge.

91 ing their hospitalization and up to 2 months after discharge.

92 ries had higher rates of long-term mortality after discharge.

93 2013 and analyzed readmissions over 30 days after discharge.

94 al research studies evaluating ARF survivors after discharge.

95 l outcomes occurring after the first 30 days after discharge.

96 on rates and hospital 30-day mortality rates after discharge.

97 with 46.3% occurring between days 30 and 90 after discharge.

98 od culture, and wound culture) in the 7 days after discharge.

99 patients returned from Ziv Hospital to Syria after discharge.

100 y, during hospitalization, and up to 2 weeks after discharge.

101 and/or hospitalization during the first year after discharge.

102 atient or observation status) within 30 days after discharge.

103 ed with postoperative readmissions and death after discharge.

104 and 1,185 (4.6%) died between 8 and 30 days after discharge.

105 L) improvement (>/=1 log10 decline) 6 months after discharge.

106 d, followed by 5 phone calls in the 10 weeks after discharge.

107 MI hospitalization, 32.6% became nonadherent after discharge.

108 esponsiveness to stimulation, and persistent after-discharge.

109 The suicide rate was highest within 3 months after discharge (1132; 95% CI, 874-1467) and among patie

110 Medicare fee-for-service eligibility 30 days after discharge, 18.5% of patients were readmitted withi

111 ity risks to decline 50% from maximum values after discharge, (2) time required for the adjusted read

112 ted continuous abstinence rates for 6 months after discharge (27% vs 16% for standard care; RR, 1.70

113 d rehospitalization for respiratory problems after discharge (28.3% vs 51.1%; P = .03); 39.5% vs 50%

114 7; 95% CI, 0.17-0.81; p = 0.005) and 90 days after discharge (37.8% vs. 70.6%; relative risk = 0.47;

115 scores in the PACU; 4 [3-7] for pain scores after discharge; 6.7 [3.3-10] for opioid use after disch

116 diogenic shock patients in the first 60 days after discharge (adjusted HR: 1.62; 95% confidence inter

117 discharge and patient adherence at 12 months after discharge, adjusting for patient baseline sociodem

118 ry prevention medications at the time of and after discharge after AMI is unknown.

119 at shorter intervals of 6 months and 1 year after discharge also showed no significant difference be

120 xcluding 916 patients who progressed to ESRD after discharge, although it was significantly amplified

121 At 6 months and 2 years after discharge among beneficiaries 66 to 75 years of ag

122 d emergency department visits within 30 days after discharge among patients undergoing a variety of s

123 d with BP elevation during the first 2 years after discharge among previously normotensive adults.

124 sociated with receiving an ICD within 1 year after discharge and 2-year mortality associated with ICD

125 ty, attention, and associative memory 1 week after discharge and 6 and 12 months later.

126 readmission risk was highest on days 2 to 4 after discharge and declined thereafter, and women were

127 rtional over time, being highest immediately after discharge and decreasing thereafter.

128 owed up every 3 months during the first year after discharge and every 6 months in the second year.

129 o be unrelated to the interventions (seizure after discharge and intracerebral haemorrhage in the rec

130 to vital statistics data to obtain mortality after discharge and matched to New York's administrative

131 hage may depend primarily on optimizing care after discharge and may improve functional outcomes at 3

132 in the use of these therapies in the 30 days after discharge and patient adherence at 12 months after

133 -Hispanic whites) who wanted to quit smoking after discharge and received a tobacco dependence interv

134 ion was largely driven by readmissions early after discharge and was not significant in landmark anal

135 dicaid coverage and more cardiologist visits after discharge and who participated in cardiac rehabili

136 they affect early readmissions (0 to 7 days after discharge) and late readmissions (8 to 30 days aft

137 s within 30 days and between 31 and 180 days after discharge) and viral load (VL) improvement (>/=1 l

138 e collected at baseline, post-test (3 months after discharge), and 3 months after post-test (6 months

139 ntation, twice monthly in the first 3 months after discharge, and at each follow-up visit until month

140 rams to target vulnerabilities predischarge, after discharge, and during re-presentation to the emerg

141 Patients were contacted 3 mo after discharge, and electronic records were accessed to

142 mon indication for readmission was infection after discharge, and readmission was associated with wor

143 ed with smaller brain volumes up to 3 months after discharge, and that smaller brain volumes are asso

144 of death between the first day and 10 years after discharge, and to compare risks between adversity-

145 of spontaneous activity, mechanically evoked after-discharges, and/or increased responses to mechanic

146 after discharge; 6.7 [3.3-10] for opioid use after discharge; and 6 of 23 [26.1%] for incidence of na

147 and survival was 17.7% with median survival after discharge being 20.6 months.

148 and received rehabilitation within 3 months after discharge between 2000 and 2010.

149 Clinicians may help protect patients after discharge by serving as a liaison between primary

150 The IV iron group had higher Hb 4 weeks after discharge compared with the usual care group (1.9

151 However, at 12 months after discharge, compared with white men, black and Hisp

152 of care complemented by 30 formal interviews after discharge concerning the experiences of the 29 pat

153 he 9136 patients surviving the first 30 days after discharge constituted the study population.

154 me was high patient coping during the 7 days after discharge defined as scores <20 on the validated p

155 a 30% decline in eGFR at 30, 60, and 90 days after discharge demonstrated adjusted hazard ratios (95%

156 ssion, and quality of life at 1 and 6 months after discharge (EQ-5D-5L [EuroQol Group, 5-level] quest

157 for an anticoagulant was filled immediately after discharge for 77 (1.5%) patients, and a low-molecu

158 he CASI score was assessed more than 45 days after discharge for 94.3% of participants.

159 The study drug was continued after discharge for a median 11.3 months.

160 risk of rehospitalization in the first month after discharge for acute myocardial infarction (AMI).

161 across conditions, women are at highest risk after discharge for acute myocardial infarction.

162 cords and was examined at 90 days and 1 year after discharge for beta-blockers, platelet P2Y12 recept

163 thly trends in 30-day RARRs and 30-day RAMRs after discharge for each condition.

164 Home health care and PAC use after discharge for hospitalized children is infrequent,

165 r hospitals to minimize readmissions shortly after discharge for several conditions, with percutaneou

166 ormation), and improvement of patient status after discharge (for example, satisfaction).

167 e in the alcohol-dependent group for 90 days after discharge from 6 weeks of inpatient treatment.

168 0.90; 95% CI, 0.83 to 0.97) and were higher after discharge from a for-profit hospital (IRR, 1.33; 9

169 ch to predict all-cause readmissions 30 days after discharge from a heart failure hospitalization and

170 spitalization rates were significantly lower after discharge from a hospital that had an outpatient p

171 ed nurse combined with a telephone follow-up after discharge from a nurse practitioner.

172 daily risk of rehospitalization/death 1 year after discharge from a population of Medicare fee-for-se

173 Unplanned readmissions after discharge from acute care for traumatic injury are

174 After discharge from acute care hospitals in 3 states, E

175 emergency department, or die within 30 days after discharge from an acute hospitalization, we conduc

176 ors of EVD in Sierra Leone, at various times after discharge from an Ebola treatment unit (ETU), in t

177 The frequency of early stroke after discharge from an emergency department with a diag

178 survivors were defined as those who survived after discharge from first hospitalization with a diagno

179 A regular screening of post-ICU patients after discharge from hospital should be an integral part

180 healthcare providers and ancillary services after discharge from hospital.

181 d nurse 3 and 10 days and 1, 3, and 6 months after discharge from hospital.

182 fast-track surgery, they often come to light after discharge from hospital.

183 igh responsiveness (16-31 point improvements after discharge from hospitalization; standardized respo

184 nt of septic and nonseptic patients 6 months after discharge from ICU.

185 of recurrent biliary events in the 365 days after discharge from index admission.

186 vices recently identified 30-day readmission after discharge from inpatient rehabilitation facilities

187 hen 20 mg daily until the earliest of 3 days after discharge from intensive care, study day 28, or de

188 y help patients and families face challenges after discharge from intensive care.

189 primary outcome was mortality up to 90 days after discharge from PICU.

190 To quantify the rates of suicide after discharge from psychiatric facilities and examine

191 The suicide rate after discharge from psychiatric facilities was the main

192 30 days on surveys taken 4, 8, and 12 months after discharge from residential treatment.

193 We hypothesized that photodegradation after discharge from the dark sedimentary environment re

194 ior (47.8%) and occurred within the 2 months after discharge from the Ebola treatment center.

195 ut of 6 survivors presented ocular disorders after discharge from the Ebola treatment center.

196 -day tobacco abstinence at 6-month follow-up after discharge from the hospital; secondary outcomes in

197 Patients were followed 6 months after discharge from the ICU for length of hospital stay

198 increased cost and decreased quality of life after discharge from the ICU.

199 codes were used to identify ischemic strokes after discharge from the index hospitalization for surge

200 rcentage of patients who had early follow-up after discharge from the index hospitalization was 38.3%

201 additional hospitalizations during the year after discharge from the index hospitalization, varying

202 ent is significantly increased in the months after discharge from the intensive care unit.

203 012 to incorporate inpatient BB continuation after discharge from the postanesthesia care unit.

204 Use of opioids after discharge from the postanesthesia care unit.

205 tcome was followed up between 2 and 14 years after discharge from the rehabilitation center.

206 tested positive for Ebola virus at 114 days after discharge from the treatment unit; specimens taken

207 Safe sex practices should be observed after discharge from treatment centers.

208 r, patients with follow-up more than 6 weeks after discharge had lower adherence at both 90 days (56.

209 exist on whether the use of early follow-up after discharge has improved over time.

210 al costs or on medical utilization and costs after discharge have been done.

211 on had a greater risk of all-cause mortality after discharge (hazard ratio, 1.38; 95% CI, 1.34-1.46).

212 skilled nursing facility compared with that after discharge home were 1.41 (95% CI, 0.72-2.76) for p

213 rienced recurrent or sustained desaturations after discharge home.

214 to PAC facilities was 36% compared with 51% after discharge home.

215 ients, including 863 with IBD, alive 30 days after discharge, IBD was associated with hazard ratios o

216 One year after discharge, ICU survivors received a survey contain

217 llow-up clinic visit occurred 1 week or less after discharge in 5542 (26.4%) patients, 1 to 2 weeks i

218 rse event (death) which occurred immediately after discharge in a patient with severe, end stage dise

219 antibiotics, use of intravenous antibiotics after discharge in children with complicated appendiciti

220 There were no major adverse cardiac events after discharge in either group.

221 ncy department (ED) visits, and readmissions after discharge in general medical patients.

222 harges to mechanical stimuli and exaggerated after-discharges in rats with bortezomib CIPN.

223 ence of spontaneous activity and/or abnormal after-discharges in response to mechanical and heat stim

224 ation, whereas the modality shift and evoked after-discharges in the VPM thalamic neurons contribute

225 Other significant predictors of mortality after discharge included maximum head injury score on Ab

226 ulative mortality rate among NCTPs at 1 year after discharge is significant, particularly in the pres

227 whether this impairment resolves or persists after discharge is unknown.

228 Whether this survival benefit persists after discharge is unknown.

229 HHC) and facility-based postacute care (PAC) after discharge is well documented for adults, to our kn

230 spitalizations (readmissions to the hospital after discharge) is unknown.

231 servational study and followed up for 1 year after discharge (mean [SD] age, 33.9 [16.3] years; 79% w

232 1 [0-5] and 3.5 [0-6.8], respectively), pain after discharge (median [IQR], 3 [2-5] and 3 [1-5.5], re

233 -5] and 3 [1-5.5], respectively), opiate use after discharge (median [IQR], 6.7 [5-10] and 6.7 [3.3-1

234 common readmission diagnoses were infections after discharge (n = 10) and vascular events (n = 6).

235 GFR decline of >/=30% at 30, 60, and 90 days after discharge occurred in 3.1%, 2.5%, and 2.6%, of sur

236 Death after discharge occurred in 69 patients (1.4%).

237 nded, the modality shifted, and long-lasting after-discharges occurred only in VPM V2 neurons.

238 s the strongest factor associated with death after discharge (odds ratio, 6.7; 95% CI, 2.4-19.3).

239 inistered dose, and a prolonged surveillance after discharge of 48 h.

240 ailed treatment, with a median time to death after discharge of 9.9 months (IQR 4.2-17.4).

241 ss spectrometry enables analysis of a casing after discharge of a firearm revealing organic signature

242 Testing for pathogen excretion was continued after discharge of the patient.

243 as neuropsychologically impaired 3-6 months after discharge; of these, 23 provided 12-month follow-u

244 The impact of spontaneous bleeding occurring after discharge on long-term mortality is unknown.

245 Six months after discharge, only 5% of those not recognized as havi

246 By the end of 1 year after discharge, only one third of all AMI survivors fil

247 ral edema, orthopnea) contribute to outcomes after discharge or how well decongestion is maintained.

248 interval, 0.87-0.94), 28 more home-time days after discharge (P<0.001), and lower all-cause mortality

249 After discharge, parents recorded all analgesics they ga

250 responses and also reduced the extent of the after-discharge phase of the seizure.

251 , and utilization of intravenous antibiotics after discharge ranged from 0% to 91.7% across hospitals

252 Case-mix-adjusted mortality rates after discharge ranged from 0.43 to 0.91 per patient-yea

253 ock, and cardiology follow-up within 2 weeks after discharge relative to patients who did not receive

254 al for CR participated within 1 and 6 months after discharge, respectively.

255 s or behaviors and those in the first months after discharge should be a particular focus of concern.

256 MR, as well as XRD data on lithiated sample (after discharge) show that the material is associated wi

257 After discharge, study controls received usual care (spo

258 Visits after discharge, support groups, and clinics have been p

259 Certain complications occurred frequently after discharge: surgical site infections (66.0%), urina

260 onary event recurrence within the first year after discharge than patients without FH despite the wid

261 rates of death or readmission in the 30 days after discharge than those discharged from nonteaching h

262 underwent a structured examination 2 months after discharge (the baseline of the present study).

263 ion was a risk factor for VTE the first year after discharge, the excess risk was not greater in pati

264 After discharge, the half-strength apple juice/preferred

265 After discharge, the primary end point occurred in 8.6%

266 67 (95% confidence interval [CI], 3.12-4.32) after discharge to 1.40 (95% CI 1.26-1.57) by year 2.

267 latively escalated at 1, 3, 6, and 12 months after discharge to 18.5%, 26.4%, 31.3%, and 40.5%, respe

268 The adjusted hazard ratios (HRs) for death after discharge to a skilled nursing facility compared w

269 low-up of survivors should begin immediately after discharge to address sequelae as they arise and re

270 Five-year overall survival after discharge to PAC facilities was 36% compared with

271 Antibiotics are often employed after discharge to prevent treatment failure in children

272 in the hospital, as well as 3 and 12 months after discharge, to determine patient survival, function

273 es across hospitals in hospital 30-day RAMRs after discharge varied by condition: HF, 0.008% (95% CI,

274 AT score from hospital discharge to 3 months after discharge was -3.0 (95% CI -4.4 to -1.6), which co

275 The median delay after discharge was 350 days (IQR 223-491).

276 Mortality at 1 year after discharge was also highest for patients with an el

277 sician-adjudicated events over the 12 months after discharge was assessed with the kappa statistic.

278 Early outpatient follow-up after discharge was associated with a small increase in

279 gh-intensity statins at 6 months and 2 years after discharge was defined by a proportion of days cove

280 isk of premature death during the first year after discharge was markedly higher than the risk of dea

281 [17 of 20] before surgery vs 83% [16 of 20] after discharge) was higher than survey adherence (65% t

282 After discharge, we established a new follow-up clinic w

283 lower, whereas Medicare costs in the 30 days after discharge were $332 higher (P < 0.001 for both).

284 mean hospital 30-day RARRs and 30-day RAMRs after discharge were 24.6% and 8.4% for HF, 19.3% and 7.

285 30-day risk-adjusted mortality rates (RAMRs) after discharge were calculated for each condition in ea

286 Delusional memories 28 days after discharge were common (70%) yet unrelated to delir

287 ach hospital's 30-day RARRs and 30-day RAMRs after discharge were examined for each condition.

288 rgone coronary artery bypass surgery 30 days after discharge were followed up for as long as 1 year (

289 out morbidity and readmission within 30 days after discharge were gathered from medical records.

290 ve mortality rates at 1, 3, 6, and 12 months after discharge were investigated using the Social Secur

291 Death alone and major adverse kidney events after discharge were most common in the pneumonia + acut

292 Changes in HRQL before discharge and 1 week after discharge were similar (P > .05 for all comparison

293 hly changes in 30-day RARRs and 30-day RAMRs after discharge were weakly positive: HF, 0.066 (95% CI,

294 o be on optimal therapy by the end of 1 year after discharge, which is driven by a sex disparity in t

295 ajor adverse cardiovascular events at 1 year after discharge, which persisted for up to 5 years after

296 patient was readmitted to hospital 9 months after discharge with symptoms of acute meningitis, and w

297 ition and executive function 3 and 12 months after discharge with the use of the Repeatable Battery f

298 One study suggested that prolonged therapy (after discharge) with enoxaparin sodium may prevent VTE

299 (4.8%) had bleeding-related hospitalization after discharge, with the highest incidence of bleeding-

300 rose from days 1 to 3 and increased further after discharge, with the trajectory dependent on the da